Cell and Gene Therapy CROs Market by Roots Analysis


Emerging biologic classes, such as cell and gene therapies, are responsible for driving evolutionary change within the contract research services industry, with stakeholders competing to consolidate their offerings and comply to rapidly changing regulatory guidelines

Emerging biologic classes, such as cell and gene therapies, are responsible for driving evolutionary change within the contract research services industry, with stakeholders competing to consolidate their offerings and comply to rapidly changing regulatory guidelines

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell and Gene Therapy CROs Market, 2021-2030

 

The report features an extensive study of the current market landscape and the likely future potential of the cell and gene therapy CROs market, over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field. In addition to other elements, the study includes:

  • An overview of the current market landscape of cell and gene therapy services market, and details of the cell and gene therapy CROs.
  • Elaborate profiles of companies that are engaged in the development of single-use bioreactors.
  • A benchmark analysis of the various companies to compare their existing capabilities within and beyond their peer groups and identify opportunities to become more competitive in the industry.
  • A detailed analysis of the various partnerships inked between CROs offering cell and gene therapy related services, that have been adopted by stakeholders engaged in this domain since 2015.
  • A detailed analysis of the various mergers and acquisitions that have taken place in this domain since 2015.
  • A detailed acquisition target analysis, offering a means for the industry stakeholders to identify potential acquisition targets.
  • An in-depth analysis of cell therapy developers that are anticipated to partner with contract research organizations and have been shortlisted on the basis of several relevant parameters.
  • An in-depth analysis of gene therapy developers that are anticipated to partner with contract research organizations and have been shortlisted on the basis of several relevant parameters.
  • A detailed clinical trial analysis of ongoing clinical studies for the evaluation of various cell and gene therapy product candidates.
  • A discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry's evolution.

 

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

  • Type of Therapy
  • Cell Therapy
  • Gene Therapy

 

  • Scale of Operation
  • Clinical Operations
  • Preclinical Operations
  • Drug Discovery Operations

 

  • Therapeutic Area
  • Oncological Disorders
  • Infectious Disorders
  • Autoimmune Disorders
  • Rare / Genetic Disorders
  • Cardiovascular Disorders
  • Metabolic Disorders
  • Blood Disorders
  • Neurological Disorders
  • Ophthalmological Disorders
  • Other Therapeutic Areas

 

  • Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific
  • Latin America (LATM)
  • Middle East and North Africa (MENA)

 

Transcripts of interviews held with the following senior level representatives of stakeholder companies

Key companies covered in the - https://www.rootsanalysis.com/reports/230/request-sample.html

 

  • Altasciences
  • CATO SMS
  • Charles River Laboratories
  • Covance
  • Creative Biolabs
  • IQVIA
  • Medpace
  • PPD
  • Precision for Medicine
  • QPS
  • Accelera
  • Evotec
  • ICON
  • JSB Solutions
  • Quality Assistance
  • CMIC Group
  • Pharmaseed

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html

 

Other Recent Offerings

  1. Patient Recruitment Market
  2. Digital Solutions for Biomarkers Market
  3. Pharmaceutical Life Sciences Real World Evidence

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis